Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

MHRA approves drug to treat rare triglycerides disorder

The medicine is administered as a 25 mg injection under the skin once every three months. Patients or their caregivers can give the injection after receiving training.

iStock
MHRA seeks closer ties with US FDA on MedTech and AI regulation

The MHRA-FDA Pioneer Programme, announced in June, establishes dedicated reciprocal liaison roles within the two regulators.

Getty Images
Covid Care

A report says measures to protect care home residents from Covid were delayed, highlighting concerns about the response to the pandemic and resident safety.

iStock